Form 4 for SUPN SUPERNUS PHARMACEUTICALS, INC.
Accepted 2025-03-05 00:00:00 ET · period of report 2025-03-05 · accession 0001628280-25-010437 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-03-05 | 2025-03-05 | SUPN | Rubin Jonathan | SVP, Chief Medical Off | F - Tax | $33.05 | -1,468 | 9,635 | -13% | -$48.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-05 | F | D | 577 | $33.05 | 10,212 | D | — | — | (F1) Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the vesting of Restricted Stock Units. |
| 2 | Common | Common Stock | 2025-03-05 | F | D | 314 | $33.05 | 10,789 | D | — | — | (F1) Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the vesting of Restricted Stock Units. |
| 3 | Common | Common Stock | 2025-03-05 | F | D | 577 | $33.05 | 9,635 | D | — | — | (F1) Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the vesting of Restricted Stock Units. |